BIOGEN INC's ticker is and the CUSIP is 09062X953. A total of 9 filers reported holding BIOGEN INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76 | -99.9% | 11,900 | -92.1% | 0.00% | 0.0% |
| Q3 2022 | $84,000 | -20.8% | 150,000 | +2900.0% | 0.00% | 0.0% |
| Q2 2022 | $106,000 | -15.2% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $125,000 | -91.2% | 5,000 | -89.7% | 0.00% | -87.5% |
| Q4 2021 | $1,421,000 | +89.7% | 48,700 | +38.7% | 0.01% | +100.0% |
| Q3 2021 | $749,000 | -14.9% | 35,100 | -32.5% | 0.00% | 0.0% |
| Q2 2021 | $880,000 | +64.5% | 52,000 | +420.0% | 0.00% | +33.3% |
| Q1 2021 | $535,000 | -80.8% | 10,000 | -80.8% | 0.00% | -80.0% |
| Q4 2020 | $2,791,000 | +36.0% | 52,000 | 0.0% | 0.02% | +15.4% |
| Q3 2020 | $2,052,000 | -29.1% | 52,000 | -10.3% | 0.01% | -45.8% |
| Q2 2020 | $2,894,000 | +54.3% | 58,000 | -16.4% | 0.02% | +33.3% |
| Q1 2020 | $1,876,000 | -2.7% | 69,400 | -62.3% | 0.02% | 0.0% |
| Q4 2019 | $1,929,000 | -38.9% | 184,100 | -6.5% | 0.02% | -30.8% |
| Q3 2019 | $3,156,000 | -49.4% | 197,000 | -9.9% | 0.03% | -39.5% |
| Q2 2019 | $6,238,000 | -56.6% | 218,700 | -30.2% | 0.04% | -67.4% |
| Q1 2019 | $14,369,000 | +133.3% | 313,500 | +12.2% | 0.13% | +144.4% |
| Q4 2018 | $6,160,000 | +139.5% | 279,400 | +8.3% | 0.05% | +184.2% |
| Q3 2018 | $2,572,000 | -29.1% | 257,900 | +57.5% | 0.02% | -42.4% |
| Q2 2018 | $3,627,000 | -39.0% | 163,700 | -3.0% | 0.03% | -31.2% |
| Q1 2018 | $5,948,000 | +108.0% | 168,700 | -46.0% | 0.05% | +77.8% |
| Q4 2017 | $2,860,000 | +239.7% | 312,300 | +47.0% | 0.03% | +285.7% |
| Q3 2017 | $842,000 | -42.8% | 212,400 | -5.0% | 0.01% | -46.2% |
| Q2 2017 | $1,473,000 | +64.9% | 223,500 | +115.1% | 0.01% | +62.5% |
| Q1 2017 | $893,000 | -29.3% | 103,900 | -44.7% | 0.01% | -27.3% |
| Q4 2016 | $1,263,000 | +7.5% | 187,800 | 0.0% | 0.01% | -8.3% |
| Q3 2016 | $1,175,000 | -34.7% | 187,800 | +45.2% | 0.01% | -7.7% |
| Q2 2016 | $1,800,000 | +29.4% | 129,300 | +33.6% | 0.01% | +30.0% |
| Q1 2016 | $1,391,000 | +13.3% | 96,800 | -19.1% | 0.01% | +11.1% |
| Q4 2015 | $1,228,000 | -79.1% | 119,700 | +40.5% | 0.01% | -74.3% |
| Q3 2015 | $5,873,000 | +300.1% | 85,200 | +8.3% | 0.04% | +250.0% |
| Q2 2015 | $1,468,000 | +1165.5% | 78,700 | +330.1% | 0.01% | +900.0% |
| Q1 2015 | $116,000 | -21.1% | 18,300 | +48.8% | 0.00% | 0.0% |
| Q4 2014 | $147,000 | – | 12,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 228,400 | $64,635,000 | 0.07% |
| SIMPLEX TRADING, LLC | 193,100 | $67,376,000 | 0.06% |
| HRT FINANCIAL LP | 8,000 | $2,263,000 | 0.01% |
| SG Americas Securities, LLC | 35,100 | $749,000 | 0.00% |
| Allianz Asset Management GmbH | 2,700 | $764,000 | 0.00% |
| JPMORGAN CHASE & CO | 33,600 | $9,508,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 7,500 | $2,122,000 | 0.00% |